A Cost-Effectiveness Analysis of Palbociclib and Other Aromatase Inhibitors for Treatment of Advanced Breast Cancer

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.03.1589
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Combination of Aromatase Inhibitors With Metronomic Capecitabine: A New Chemoendocrine Treatment for Advanced Breast Cancer

Journal of Cancer Therapy
2019English

A Systematic Review and Methodological Evaluation of Published Cost-Effectiveness Analyses of Aromatase Inhibitors Versus Tamoxifen in Early Stage Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer

Breast Care
SurgeryOncology
2016English

Influence of CYP19A1 Polymorphisms on the Treatment of Breast Cancer With Aromatase Inhibitors: A Systematic Review and Meta-Analysis

BMC Medicine
Medicine
2015English

Aromatase and COX in Breast Cancer: Enzyme Inhibitors and Beyond

Journal of Steroid Biochemistry and Molecular Biology
Molecular MedicineCell BiologyMolecular BiologyBiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2007English

Letrozole (CGS 20267), a New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1996English

Review of Hormone-Based Treatments in Postmenopausal Patients With Advanced Breast Cancer Focusing on Aromatase Inhibitors and Fulvestrant

ESMO Open
Cancer ResearchOncology
2016English

Cost-Effectiveness of Palbociclib Plus Letrozole Versus Letrozole Alone as a First-Line Treatment in Women With Oestrogen Receptor-Positive, HER2-negative, Advanced Breast Cancer. Revised Results for the Swiss Health Care Setting

Breast Cancer Research and Treatment
Cancer ResearchOncology
2017English

Cost-Effectiveness Analysis of Annual Breast Cancer Screening in Japan.

Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening)
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy